VIE Joins COVID-19 Fight, CBMG To Be Taken Private, FDA Postpones Decision On EM-100, ONTX On Watch

Today's Daily Dose brings you news about Cellular Biomedicine to be taken private, delay in the FDA decision on Bausch Health's EM-100 proposed for the treatment of ocular itching associated with allergic conjunctivitis, progress in EyeGate's MoxiGel, a combination product for the treatment of bacterial conjunctivitis, and anticipated milestones of Onconova Therapeutics, among others.

from RTT - Biotech https://ift.tt/33Tgd2u
via IFTTT